Septerna, Inc. (SEPN)
38.96
-0.17
(-0.43%)
USD |
NASDAQ |
Oct 01, 13:22
Septerna Market Cap : 1.779B for Oct. 1, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| September 30, 2026 | 1.787B |
| September 29, 2026 | 1.787B |
| September 28, 2026 | 1.815B |
| September 25, 2026 | 1.725B |
| September 24, 2026 | 1.741B |
| September 23, 2026 | 1.756B |
| September 22, 2026 | 1.844B |
| September 21, 2026 | 1.760B |
| September 18, 2026 | 1.767B |
| September 17, 2026 | 1.804B |
| September 16, 2026 | 1.755B |
| September 15, 2026 | 1.775B |
| September 14, 2026 | 1.806B |
| September 11, 2026 | 1.759B |
| September 10, 2026 | 1.724B |
| September 09, 2026 | 1.734B |
| September 08, 2026 | 1.707B |
| September 04, 2026 | 1.678B |
| September 03, 2026 | 1.681B |
| September 02, 2026 | 1.713B |
| September 01, 2026 | 1.721B |
| August 31, 2026 | 1.742B |
| August 28, 2026 | 1.777B |
| August 27, 2026 | 1.848B |
| August 26, 2026 | 1.838B |
| Date | Value |
|---|---|
| August 25, 2026 | 1.886B |
| August 24, 2026 | 1.850B |
| August 21, 2026 | 1.827B |
| August 20, 2026 | 1.863B |
| August 19, 2026 | 2.006B |
| August 18, 2026 | 2.000B |
| August 17, 2026 | 2.019B |
| August 14, 2026 | 2.032B |
| August 13, 2026 | 2.061B |
| August 12, 2026 | 2.201B |
| August 11, 2026 | 2.181B |
| August 10, 2026 | 1.774B |
| August 07, 2026 | 1.773B |
| August 06, 2026 | 1.805B |
| August 05, 2026 | 1.741B |
| August 04, 2026 | 1.751B |
| August 03, 2026 | 1.571B |
| July 31, 2026 | 1.547B |
| July 30, 2026 | 1.580B |
| July 29, 2026 | 1.510B |
| July 28, 2026 | 1.526B |
| July 27, 2026 | 1.504B |
| July 24, 2026 | 1.487B |
| July 23, 2026 | 1.503B |
| July 22, 2026 | 1.536B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Cocrystal Pharma, Inc. | 15.86M |
| CNBX Pharmaceuticals, Inc. | 0.1476M |
| GB Sciences, Inc. | 0.0407M |
| Arvinas, Inc. | 497.59M |
| Fulcrum Therapeutics, Inc. | 281.87M |
Market Cap Related Metrics
| PS Ratio | 17.73 |
| Price to Book Value | 4.601 |
| Price to Free Cash Flow | 16.68 |
| Price | 38.96 |
| Earnings Yield | -1.40% |